VEGF in the nervous system

Organogenesis

Volumn 6, Issue 2, 2010, Pages 107-114

  Rosenstein, Jeffrey M ^a   Krum, Janette M ^a   Ruhrberg, Christiana ^b  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Angiogenic niche; Blood vessel; Endothelial cell; Glia; Neurogenesis; Neuron; VEGF

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; BRAIN; NERVE CELL; NERVE DEGENERATION; NERVE REGENERATION; NERVOUS SYSTEM DEVELOPMENT; NEURAL STEM CELL; NEUROPROTECTION; NONHUMAN; REVIEW;

VERTEBRATA;

EID: 77953494291     PISSN: 15476278     EISSN: 15558592     Source Type: Journal    
DOI: 10.4161/org.6.2.11687     Document Type: Review

References (86)

1. Ruhrberg C. Growing and shaping the vascular tree: Multiple roles for VEGF. BioEssays 2003; 25:1052-60.
2. Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev 1997; 18:425.
3. Dvorak HF, Brown LF, Detmar M, et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability and angiogenesis. Am J Pathol 1995; 146:1029-39.
4. Ferrara N. VEGF: An update on biological and therapeutic aspects. Curr Opin Biotechnol 2000; 11:617-24.
5. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003; 9:669-76.
6. Fong GH, Rossant J, Gertsenstein M, et al. Role of the Flt1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995; 376:6535-670.
7. Shalaby F, Rossant J, Yamaguchi TP, et al. Failure of blood island formation and vasculogenesis in Flk1-deficient mice. Nature 1995; 376:62-6.
8. Carmeliet P, Ferreira V, Breier G, et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996; 380:435-9.
9. Ferrara N, Carver-Moore K, Chen H, et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 1996; 380:439-42.
10. Kawasaki T, Kitsukawa T, Bekku Y, et al. A requirement for neuropilin1 in embryonic vessel formation. Development 1999; 126:4895-902.
11. Rosenstein JM, Krum JM. New roles for VEGF in nervous tissue beyond blood vessels. Exp Neurol 2004; 187:246-53.
12. Carmeliet P, Storkebaum E. Vascular and neuronal effects of VEGF in the nervous system: Implications for neurological disorders. Semin Cell Dev Biol 2002; 13:39-53.
13. Storkebaum E, Carmeliet P. VEGF: A critical player in neurodegeneration. J Clin Invest 2004; 113:14-8.
14. Ruhrberg C, Gerhardt H, Golding M, et al. Spatially restricted patterning cues provided by heparin-binding VEGFA control blood vessel branching morphogenesis. Genes Dev 2002; 16:2684-98.
15. Haigh JJ, Morelli PI, Gerhardt H, et al. Cortical and retinal defects caused by dosage-dependent reductions in VEGFA paracrine signaling. Dev Biol 2003; 262:225-41.
16. Raab S, Beck H, Gaumann A, et al. Impaired brain angiogenesis and neuronal apoptosis induced by conditional homozygous inactivation of vascular endothelial growth factor. Thromb Haemost 2004; 91:595-605.
17. Bar T. Patterns of vascularization in the developing cerebral cortex. Ciba Found Symp 1983; 100:20-36.
18. Risau W. Mechanisms of angiogenesis. Nature 1997; 386:671-4.
19. Breier G, Albrecht U, Sterrer S, et al. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation. Development 1992; 114:521-32.
20. Gerhardt H, Golding M, Fruttiger M, et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003; 161:1163-77.
21. Rosenstein JM, Mani N, Silverman WF, et al. Patterns of brain angiogenesis after vascular endothelial growth factor administration in vitro and in vivo. Proc Natl Acad Sci USA 1998; 95:7086-91.
22. Krum JM, Mani N, Rosenstein JM. Angiogenic and astroglial responses to vascular endothelial growth factor administration in adult rat brain. Neuroscience 2002; 110:589-604.
23. Zhang ZG, Zhang L, Jiang Q, et al. VEGF enhances angiogenesis and promotes blood brain barrier leakage in the ischemic brain. J Clin Invest 2000; 106:829-38.
24. Proescholdt MA, Heiss JD, Walbridge S, et al. Vascular endothelial growth factor (VEGF) modulates vascular permeability and inflammation in rat brain. J Neuropathol Exp Neurol 1999; 58:613-27.
25. van Bruggen N, Thibodeaux H, Palmer JT, et al. VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 1999; 104:1613-20.
26. Hiratsuka S, Minowa O, Kuno J, et al. Flt1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc Natl Acad Sci USA 1998; 95:9349-54.
27. Kearney JB, Kappas NC, Ellerstrom C, et al. The VEGF receptor flt1 (VEGFR1) is a positive modulator of vascular sprout formation and branching morphogenesis. Blood 2004; 103:4527-35.
28. Gerhardt H, Ruhrberg C, Abramsson A, et al. Neuropilin1 is required for endothelial tip cell guidance in the developing central nervous system. Dev Dyn 2004; 231:503-9.
29. Kitsukawa T, Shimono A, Kawakami A, et al. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development 1995; 121:4309-18.
30. Gu C, Rodriguez ER, Reimert DV, et al. Neuropilin1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev Cell 2003; 5:45-57.
31. Soker S, Takashima S, Miao HQ, et al. Neuropilin1 is expressed by endothelial and tumor cells as an isoform specific receptor for vascular endothelial growth factor. Cell 1998; 92:735-45.
32. Lambrechts D, Storkebaum E, Morimoto M, et al. VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic death. Nat Gen 2003; 34:383-93.
33. Oosthuyse B, Moons L, Storkebaum E, et al. Deletion of the hypoxia response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Gene 2001; 28:131-8.
34. Sopher BL, Thomas PS Jr, LaFevre-Bernt MA, et al. Androgen receptor YAC transgenic mice recapitulate SBMA motor neuronopathy and implicate VEGF164 in the motor neuron degeneration. Neuron 2004; 41:687-99.
35. Storkebaum E, Lambrechts D, Dewerchin M, et al. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosci 2005; 8:85-92.
36. Rosenstein JM, Mani N, Khaibullina A, et al. Neurotrophic effects of vascular endothelial growth factor on organotypic cortical explants and primary cortical neurons. J Neurosci 2003; 23:11036-44.
37. Silverman WF, Krum JM, Mani N, et al. Vascular, glial and neuronal effects of vascular endothelial growth factor in mesencephalic explant cultures. Neuroscience 1999; 90:1529-41.
38. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. Neuroscience 1999; 19:5731-40.
39. Sondell M, Sundler F, Kanje M. Vascular endothelial growth factor is a neurotrophic factor which stimulates axonal outgrowth through the flk1 receptor. Eur J Neurosci 2000; 12:4243-54.
40. Jin KL, Mao XO, Nagayama T, et al. Induction of vascular endothelial growth factor and hypoxiainducible factor1alpha by global ischemia in rat brain. Neuroscience 2000; 99:577-85.
41. Jin KL, Mao XO, Greenberg DA. Vascular endothelial growth factor: Direct neuroprotective effect in in vitro ischemia. Proc Natl Acad Sci USA 2000; 97:10242-7.
42. Matsuzaki H, Tamatani M, Yamaguchi A, et al. Vascular endothelial growth factor rescues hippocampal neurons from glutamate-induced toxicity: Signal transduction cascades. FASEB J 2001; 15:1218-20.
43. Svensson B, Peters M, Konig HG, et al. Vascular endothelial growth factor protects cultured rat hippocampal neurons against hypoxic injury via an antiexcitotoxic, caspase-independent mechanism. J Cereb Blood Flow Metab 2002; 22:1170-5.
44. Sondell M, Lundborg G, Kanje M. Vascular endothelial growth factor stimulates Schwann cell invasion and neovascularization of acellular nerve grafts. Brain Res 1999; 846:219-28.
45. Schratzberger P, Schratzberger G, Silver M, et al. Favorable effect of VEGF gene transfer on ischemic peripheral neuropathy. Nat Med 2000; 6:405-13.
46. Mani N, Khaibullina A, Krum JM, et al. Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: Receptor mediation and signal transduction pathways. Exp Neurol 2005; 192:394-406.
47. Eddleston M, Mucke L. Molecular profile of reactive astrocytes - implications for their role in neurologic disease. Neuroscience 1993; 54:15-36.
48. Krum JM, Rosenstein JM. VEGF mRNA and its receptor flt1 are expressed in reactive astrocytes following neural grafting and tumor cell implantation in the adult CNS. Exp Neurol 1998; 154:57-65.
49. Khaibullina AA, Rosenstein JM, Krum JM. Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. Brain Research. Dev Brain Res 2004; 148:59-68.
50. Ogunshola OO, Antic A, Donoghue MJ, et al. Paracrine and autocrine functions of neuronal vascular endothelial growth factor (VEGF) in the central nervous system. J Biol Chem 2002; 277:11410-5.
51. Zhang ZG, Tsang W, Zhang L, et al. Upregulation of neuropilin1 in neovasculature after focal cerebral ischemia in the adult rat. J Cereb Blood Flow Metab 2001; 21:541-9.
52. Raper JA. Semaphorins and their receptors in vertebrates and invertebrates. Curr Opin Neurobiol 2000; 10:88-94.
53. Jin K, Zhu Y, Sun Y, et al. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA 2002; 99:11946-50.
54. Palmer TD, Willhoite AR, Gage FH. Vascular niche for adult hippocampal neurogenesis. J Comp Neurol 2000; 425:479-94.
55. Louissaint A Jr, Rao S, Leventhal C, et al. Coordinated interaction of neurogenesis and angiogenesis in the adult songbird brain. Neuron 2002; 34:945-60.
56. Ramirez-Castillejo C, Sanchez-Sanchez F, Andreu-Agullo C, et al. Pigment epithelium-derived factor is a niche signal for neural stem cell renewal. Nat Neurosci 2006; 9:331-9.
57. Bagnard D, Vaillant C, Khuth ST, et al. Semaphorin 3Avascular endothelial growth factor165 balance mediates migration and apoptosis of neural progenitor cells by the recruitment of shared receptor. J Neurosci 2001; 21:3332-41.
58. Zhang H, Vutskits L, Pepper MS, et al. VEGF is a chemoattractant for FGF2-stimulated neural progenitors. J Cell Biol 2003; 163:1375-84.
59. Yang K, Cepko CL. Flk1, a receptor for vascular endothelial growth factor (VEGF), is expressed by retinal progenitor cells. J Neurosci 1996; 16:6089-99.
60. Robinson GS, Ju M, Shih SC, et al. Nonvascular role for VEGF: VEGFR1, 2 activity is critical for neural retinal development. FASEB J 2001; 15:1215-7.
61. Gariano RF, Hu D, Helms J. Expression of angiogenesis-related genes during retinal development. Gene Expr Patterns 2006; 6:187-92.
62. Hashimoto T, Zhang XM, Chen BY, et al. VEGF activates divergent intracellular signaling components to regulate retinal progenitor cell proliferation and neuronal differentiation. Development 2006; 133:2201-10.
63. Yourey PA, Gohari S, Su JL, et al. Vascular endothelial cell growth factors promote the in vitro development of rat photoreceptor cells. J Neurosci 2000; 20:6781-8.
64. Wada T, Haigh JJ, Ema M, et al. Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival. J Neurosci 2006; 26:6803-12.
65. Schanzer A, Wachs FP, Wilhelm D, et al. Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol 2004; 14:237-48.
66. Eichmann A, Makinen T, Alitalo K. Neural guidance molecules regulate vascular remodeling and vessel navigation. Genes Dev 2005; 19:1013-21.
67. Kolodkin AL, Ginty DD. Steering clear of semaphorins: Neuropilins sound the retreat. Neuron 1997; 19:1159-62.
68. Miao HQ, Soker S, Feiner L, et al. Neuropilin1 mediates collapsin1/semaphorin III inhibition of endothelial cell motility: Functional competition of collapsin1 and vascular endothelial growth factor165. J Cell Biol 1999; 146:233-42.
69. Bagnard D, Lohrum M, Uziel D, et al. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development 1998; 125:5043-53.
70. Carmeliet P. Blood vessels and nerves: Common signals, pathways and diseases. Nat Rev Genet 2003; 4:710-20.
71. Kutcher ME, Klagsbrun M, Mamluk R. VEGF is required for the maintenance of dorsal root ganglia blood vessels but not neurons during development. FASEB J 2004; 18:1952-4.
72. Vieira JM, Schwarz Q, Ruhrberg C. Selective requirements for neuropilin ligands in neurovascular development. Development 2007; 134:1833-43.
73. Schwarz Q, Gu C, Fujisawa H, et al. Vascular endothelial growth factor controls neuronal migration and cooperates with Sema3A to pattern distinct compartments of the facial nerve. Genes Dev 2004; 18:2822-34.
74. Bates D, Taylor GI, Minichiello J, et al. Neurovascular congruence results from a shared patterning mechanism that utilizes Semaphorin3A and Neuropilin1. Dev Biol 2003; 255:77-98.
75. Torres-Vazquez J, Gitler AD, Fraser SD, et al. Semaphorin-plexin signaling guides patterning of the developing vasculature. Dev Cell 2004; 7:117-23.
76. Serini G, Valdembri D, Zanivan S, et al. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature 2003; 424:391-7.
77. Gu C, Yoshida Y, Livet J, et al. Semaphorin 3E and plexinD1 control vascular pattern independently of neuropilins. Science 2005; 307:265-8.
78. Mukouyama YS, Gerber HP, Ferrara N, et al. Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1mediated positive feedback. Development 2005; 132:941-52.
79. Mukouyama YS, Shin D, Britsch S, et al. Sensory nerves determine the pattern of arterial differentiation and blood vessel branching in the skin. Cell 2002; 109:693-705.
80. Sun Y, Jin K, Xie L, et al. VEGF-induced neuroprotection, neurogenesis and angiogenesis after focal cerebral ischemia. J Clin Invest 2003; 111:1843-51.
81. Hayashi T, Abe K, Itoyama Y. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab 1998; 18:887-95.
82. Krum JM, Khaibullina A. Inhibition of endogenous VEGF impedes revascularization and astroglial proliferation: Roles for VEGF in brain repair. Exp Neurol 2003; 181:241-57.
83. Facchiano F, Fernandez E, Mancarella S, et al. Promotion of regeneration of corticospinal tract axons in rats with recombinant vascular endothelial growth factor alone and combined with adenovirus coding for this factor. J Neurosurg 2002; 97:161-8.
84. Widenfalk J, Lipson A, Jubran M, et al. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience 2003; 120:951-60.
85. Hobson MI, Green CJ, Terenghi G. VEGF enhances intraneural angiogenesis and improves nerve regeneration after axotomy. J Anat 2000; 197:591-605.
86. Kalaria RN, Cohen DL, Premkumar DR, et al. Vascular endothelial growth factor in Alzheimer disease and experimental cerebral ischemia. Brain Res Mol Brain Res 1998; 62:101-5.